Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Inspira Technologies Oxy BHN ( (IINN) ) has shared an update.
On July 18, 2025, Inspira Technologies announced it regained compliance with Nasdaq’s minimum bid price requirement, reflecting market confidence in its strategic direction. This milestone follows a series of achievements, including a large commercial order and government partnership, positioning the company for global distribution and long-term shareholder value. Inspira’s recent advancements, such as the clinical integration of the ART100 in U.S. hospitals and expanded manufacturing capabilities, serve as catalysts for ongoing discussions with commercial and governmental entities worldwide.
The most recent analyst rating on (IINN) stock is a Buy with a $2.00 price target. To see the full list of analyst forecasts on Inspira Technologies Oxy BHN stock, see the IINN Stock Forecast page.
Spark’s Take on IINN Stock
According to Spark, TipRanks’ AI Analyst, IINN is a Underperform.
The overall stock score reflects significant financial instability, as indicated by ongoing losses and reliance on external funding. The technical analysis shows bearish sentiment, with the stock under pressure. Valuation is challenging due to negative earnings and lack of dividend yield, making the stock less appealing to investors.
To see Spark’s full report on IINN stock, click here.
More about Inspira Technologies Oxy BHN
Inspira Technologies Oxy B.H.N. Ltd. is a commercial-stage medical device company specializing in advanced respiratory support and real-time blood monitoring solutions. The company offers the FDA-cleared INSPIRA ART100 system for cardiopulmonary bypass in the U.S. and ECMO procedures outside the U.S., and is developing the INSPIRA ART500 for oxygenation while patients remain awake. Inspira is also advancing HYLA, a proprietary blood sensor platform for continuous, non-invasive monitoring. With a growing IP portfolio and strategic operational streamlining, Inspira is positioned as a significant player in the life-support and MedTech industry.
Average Trading Volume: 952,610
Technical Sentiment Signal: Buy
Current Market Cap: $35.1M
Learn more about IINN stock on TipRanks’ Stock Analysis page.